Validation of the PDQ & DN4.

PainDETECT-Questionnaire and DN4: A Dutch validation study in patients with low back pain, neck shoulder pain or with a neuropathic pain syndrome.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23306

Enrollment

438

Registered

2011-08-18

Start date

2009-02-23

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain questionnaires Translation Validation Neuropathische pijn Vragenlijsten Vertaling Validatie

Interventions

Cross-sectional research design to study the psychometric quality of the PD-Q and the DN4 as compared to a gold standard (Diagnosis by two independant physiciqans), QST (20% of the study population)

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men & Women; 2. At least 18 years old; 3. More than 3 months pain complaints of low back pain, neck shoulder pain radiating into respectively leg(s) or arm(s) or a neuropathic pain syndrome.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with malignancy, compression fractures, ankylosing spondylitis or fibromyalgia; 2. Patients with painful syndromes of unknown origin or associated with diffuse pains, severe mental illness, chronic alcoholism or substance abuse; 3. Inability to fill in the questionnaire adequately; 4. Not capable to understand the Dutch language.

Design outcomes

Primary

Measure	Time frame
1. Outcome of the gold standard: The clinical examination serves as the goldstandard. Based on the grading system of Treede et al (2008), The gold standard is based on a standardized assessment performed by two independant working physicians; 2. Outcome of PDQ & DN4; 3. Outcome of Quantitative Sensory testing (QST) in 20% of the study population.	—

Secondary

Measure	Time frame
1. Medical comorbidity: Questionnaire with the most prevalent and relevant medical; 2. Mental health status: Hospital Anxiety Depression Scale (HADS) (Spinhoven et al. 1997); 3. Functioning: Disability Rating Index (DRI) (Salen et al. 1994); 4. Health related quality of life: Short form-36 (SF-36); 5. Pain Attribution Scale (Kraaimaat 200?). 6. prevalence of neuropathic pain in this patient groups.	—

Measure

Time frame

1. Medical comorbidity: Questionnaire with the most prevalent and relevant medical; 2. Mental health status: Hospital Anxiety Depression Scale (HADS) (Spinhoven et al. 1997); 3. Functioning: Disability Rating Index (DRI) (Salen et al. 1994); 4. Health related quality of life: Short form-36 (SF-36); 5. Pain Attribution Scale (Kraaimaat 200?). 6. prevalence of neuropathic pain in this patient groups.

—

Contacts

Public ContactH. Timmerman

Radboud University Nijmegen Medical centre Department of Anesthesiology, Pain and Palliative Care P.O.Box 9101

h.timmerman@anes.umcn.nl+31 (0)6 53371015

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)